Skip to content
BioBuzz BioBuzz

Biotech and Life Science News, Jobs, and Events for the BioHealth Capital Region

Primary Menu
  • Jobseeker
    • BioBuzz Featured Employers
      • American Gene Technologies
      • BioFactura
      • Kite
      • NextCure
    • Job Board
    • Biomanufacturing Jobs in Maryland
    • Career Resources
  • Employer
    • Employer Solutions
    • Post a Job
  • News
    • Newsletter
    • BioHealth Capital Region News
    • Philadelphia Biotech News
    • Capital Projects
    • Press Releases
  • Features
    • 5 Questions With…
    • In Conversation
    • People On The Move
    • Submit Your People On The Move
  • Events
    • Free Event Listing
  • Awards
    • 2021 Awards Winners
    • 2021 Awards Finalists
    • 2020 Awards Winners
    • 2020 Awards Finalists
  • Newsletter Subscribe

Pain Management Company Virpax Sees Promise in Potential COVID-19 Antiviral OTC

Headshot of Anthony Mack
Published on : November 12, 2021November 12, 2021 Published by : Alex Keown

Philadelphia-based Virpax Pharmaceuticals has licensed an asset, AnQlar, that has potential to be an OTC treatment for COVID-19.

Tagged in : COVID19 Epilepsy Pain Management Philadelphia PTSD Virpax
Categorized in : Philadelphia News
View All Jobs Post a Job

Annual Sponsors

Bio-Trac
CRB
Frederick Department of Economic Development
  • Online Community
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • Youtube

CONTACT US ABOUT US

Terms & Conditions  Privacy Policy
Made with ♥ in Baltimore

© 2022 BioBuzz Media™